Pioneering innovation in pharmaceutical lyophilization

The use of lyophilization – or freeze drying – in the pharma manufacturing process is central to ensuring the stability and efficacy of biopharmaceuticals and vaccines for patients worldwide. Navigating the complexities of lyophilization can be tricky, and partnering with the right CDMO service providers to ensure compliance and scale-up readiness is essential.

Explore the key considerations in lyophilization, with insights into:

Enhancing the stability, accessibility, and distribution of sensitive pharmaceuticals
Understanding lyophilization precision process analysis, from freezing to secondary drying
Examining the expanding market demand for lyophilization CDMO services
Discovering the value of strategic CDMO partnerships in advancing drug formulation and lyophilization process optimization

Download the Whitepaper

Your company email address

Please select your industry: (max 1)

Opt In?

Berne Media may store and process my information. For details, see the Privacy Notice.
Citeline (previously Pharma Intelligence UK) may contact me with updates, relevant promotions and information about products. My Information will be used in accordance with the Citeline Privacy Policy, and you withdraw your permission to receive any of our communications at any time.
Thermo Fisher Scientific (including its affiliates) may contact me about events, products, services and promotions which Thermo Fisher believes may be of interest to me via email and will process my Personal Information according to its privacy policy. I can withdraw my consent and unsubscribe at any time by e-mailing reply@thermofisher.com. I acknowledge Thermo Fisher Scientific (including its affiliates) will process my Personal Information according to its Privacy Policy, which includes information about my rights

Please complete all required fields to access the content!

Securing your samples: Strategies for safeguarding critical biological materials

To deliver these therapies to the patients who need them, their success hinges on effective storage and management to maintain integrity throughout their lifecycle. From early development to commercialization, safeguarding sensitive biological materials demands scalable storage solutions and meticulous risk mitigation strategies. Partnering with a CDMO specializing in ultracold storage and biorepository management is critical to preserving product integrity and ensuring continuity throughout every development stage. This webinar will explore how the right CDMO partner can streamline biological material storage, mitigate risks, and provide the scalability needed to support growth from clinical trials to commercial launch, empowering you to advance your pipeline with confidence. Participants will gain insight into:

A New Era of Participant Payment Services

Financial burdens are cited as one of the main barriers to clinical trial recruitment and retention, with traditional methods proving unreliable, complicated and slow. For trial sites and sponsors, the administration burden can be overwhelming, especially on a global scale. Discover how IQVIA’s Participant Payment service is transforming the participant payment landscape, simplifying the process and driving clinical trial success, by offering:

From biomarkers to regulatory compliance, and the impact of AI/ML

The field of precision medicine is rapidly evolving, enabling the development of innovative therapies highly tailored to individuals’ genetic profiles - resulting in revolutionized treatments and improved patient outcomes. Discover expert insights on the current landscape of personalized medicine, including the opportunities and challenges, including: